Daniel Barber, President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 361,354 shares at $4.17 ($1.5M) on 2026-03-10, disclosed to the SEC on 2026-03-11.
Seasonal sale ($1.5M) by President and CEO — this insider has traded AQST in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 180,677 | $753K | 50.0% |
| 2 | $4.17 | 180,677 | $754K | 50.0% |
| Total | $4.17 avg | 361,354 | $1.5M | 100% |
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-05-18 | $35K | — | Filing → |